<?xml version="1.0" encoding="UTF-8"?>
<p>Regarding the results for the laboratory changes, no relevant differences are shown between active and placebo treatment. Noticeably, a remarkable number of subjects had increases of the analyzed parameters during the in-house phase under placebo. This indicates that factors beyond treatment were causative for laboratory changes during the studies. Various aspects have been discussed in the literature especially in regard to liver enzyme increases in this context and are mostly suggested to be related to hospitalization effects but also to demographics, individual predisposition, and physiological regulation [
 <xref rid="b12" ref-type="bibr">12</xref>, 
 <xref rid="b13" ref-type="bibr">13</xref>, 
 <xref rid="b14" ref-type="bibr">14</xref>]. Our data are in line with other recently published data [
 <xref rid="b15" ref-type="bibr">15</xref>] and support the assumption that factors like the ones mentioned, not associated to the study drugs, in fact play a role in causing laboratory changes during clinical studies. 
</p>
